[Familial occlusion of central veins associated with type II familial hyperlipoproteinemia].

Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency.

Familial hyperlipoproteinemia and gallstones.

Familial combined hyperlipoproteinemia.

[Sitosterol in familial hyperlipoproteinemia type II. A randomized double-blind cross-over study].

Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.

Pseudohomozygous type II hyperlipoproteinemia.

Treatment of type II hyperlipoproteinemia with d-thyroxine.

A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

Secondary type II hyperlipoproteinemia in patients with anorexia nervosa.

Familial adhesive arachnoiditis associated with syringomyelia.

Familial pyloric atresia associated with epidermolysis bullosa.

Familial syndromes associated with neuroendocrine tumours.

Extracolonic manifestations associated with familial adenomatous polyposis.

Familial centronuclear myopathy associated with 'cardiomyopathy'.

Familial psychological factors are associated with encopresis.

Familial factors associated with malignant gliomas.

Serum Neurophysins in familial central diabetes insipidus.

$Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.$
Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.

Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.

Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report.

Central retinal artery occlusion associated with hypertriglyceridemia.

Results of colestipol therapy in Type II hyperlipoproteinemia.

Effect of lovastatin on hemorheology in type II hyperlipoproteinemia.

Achondrogenesis type I. A familial subvariant?

Suggest Documents

Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency.

Familial hyperlipoproteinemia and gallstones.

Familial combined hyperlipoproteinemia.

[Sitosterol in familial hyperlipoproteinemia type II. A randomized double-blind cross-over study].

Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.

Pseudohomozygous type II hyperlipoproteinemia.

Treatment of type II hyperlipoproteinemia with d-thyroxine.

A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

Secondary type II hyperlipoproteinemia in patients with anorexia nervosa.

Familial adhesive arachnoiditis associated with syringomyelia.

Familial pyloric atresia associated with epidermolysis bullosa.

Familial syndromes associated with neuroendocrine tumours.

Extracolonic manifestations associated with familial adenomatous polyposis.

Familial centronuclear myopathy associated with 'cardiomyopathy'.

Familial psychological factors are associated with encopresis.

Familial factors associated with malignant gliomas.

Serum Neurophysins in familial central diabetes insipidus.

Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.

Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.

Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report.

Central retinal artery occlusion associated with hypertriglyceridemia.

Results of colestipol therapy in Type II hyperlipoproteinemia.

Effect of lovastatin on hemorheology in type II hyperlipoproteinemia.

Achondrogenesis type I. A familial subvariant?

[Familial occlusion of central veins associated with type II familial hyperlipoproteinemia].

Recommend Documents

Follow Us